The present inventions relate generally to the treatment of obstructive sleep apnea by stimulating the hypoglossal nerve.
Obstructive sleep apnea (OSA) is a highly prevalent sleep disorder that is caused by the collapse of or increase in the resistance of the pharyngeal airway, often resulting from tongue obstruction. The obstruction of the upper airway is mainly caused by reduced genioglossus muscle activity during the deeper states of non-rapid eye movement (NREM) sleep. In some OSA patients, obstruction occurs predominantly during rapid eye movement (REM) sleep. This is known as REM OSA and has different cardiometabolic and neurocognitive risks. Obstruction of the upper airway causes breathing to pause during sleep. Cessation of breathing, in turn, causes a decrease in the blood oxygen saturation level, which is eventually corrected when the person wakes up and resumes breathing. The long-term effects of OSA include, but are not limited to, high blood pressure, heart failure, strokes, diabetes, headaches, and general daytime sleepiness and memory loss.
Some proposed methods of alleviating apneic events involve the use of neurostimulators to open the upper airway. Such therapy involves stimulating the nerve fascicles of the hypoglossal nerve (HGN) that innervate the intrinsic and extrinsic muscles of the tongue in a manner that prevents retraction of the tongue, which would otherwise close the upper airway during the inspiration portion of the respiratory cycle. In some instances, the trunk of the HGN is stimulated with a nerve cuff, including a cuff body and a plurality of electrically conductive contacts on the cuff body, that is positioned around the HGN trunk. The HGN trunk nerve cuff may be configured in such a manner that it can be used to selectively stimulate nerve fascicles which innervate muscles that extend the tongue, while avoiding other nerve fascicles, with what is predominantly radial vector stimulation. For example, the contacts may be axially aligned and circumferentially spaced around the perimeter of the HGN trunk. In other instances, a nerve cuff is placed on the branch of the HGN that is responsible for protruding the tongue (hereafter “HGN genioglossus muscle branch” or “HGN GM branch”). A smaller diameter cuff with two or three axially spaced contacts may be used at the HGN GM branch because the nerve fascicles within this branch generally innervate the specific tongue protrusor muscle, but not other muscles. Put another way, the entire HGN GM branch is stimulated with what is predominantly axial vector stimulation. Exemplary nerve cuffs are illustrated and described in U.S. Pat. Pub. Nos. 2018/0318577A1, 2018/0318578A1, 2019/0060646A1 and 2019/0282805, which are incorporated herein by reference in their entirety.
The present inventors have determined that conventional nerve cuffs are susceptible to improvement. In particular, the present inventors have determined that providing different nerve cuffs for the HGN trunk and HGN GM branch is not cost-effective because each nerve cuff must be separately developed and qualified, and then undergo successful clinical trials and regulatory approvals. One proposed solution to this problem in the art is to employ a helical nerve cuff that can be placed on differently sized nerve structures. The present inventors have determined that conventional helical nerve cuffs are susceptible to improvement. For example, they do not facilitate selective fascicle stimulation and, accordingly, are less than optimal for use on both the HGN trunk and the HGN GM branch.
An electrode lead in accordance with at least one of the present inventions includes an elongate lead body and a nerve cuff. The nerve cuff may include a biologically compatible, elastic, electrically insulative cuff body affixed to the distal end of the lead body, the cuff body being configured to be disposed around a nerve, having a pre-set furled helical state that defines an inner lumen, being movable to an unfurled state, and defining a length and a width in the unfurled state that is greater than the length. A plurality of electrically conductive contacts may be carried by the cuff body and spaced from one another in the width direction. A plurality of electrical conductors may be electrically connected to the electrically conductive contacts and extend through the lead body to the proximal end of the lead body. The present inventions also include systems with an implantable pulse generator or other implantable stimulation device in combination with such an electrode lead.
An electrode lead in accordance with at least one of the present inventions includes an elongate lead body and a nerve cuff. The nerve cuff may include a biologically compatible, elastic, electrically insulative cuff body affixed to the distal end of the lead body, the cuff body being configured to be disposed around a nerve, having a pre-set furled helical state that defines an inner lumen, being movable to an unfurled state, and defining a length and a width in the unfurled state that is greater than the length. First and second relatively wide electrically conductive contacts may be carried by the cuff body that are spaced from one another in the length direction and that extend in the width direction to such an extent that they extend completely around the cuff body inner lumen when the cuff body is in the pre-set furled shape. A plurality of relatively narrow electrically conductive contacts may be carried by the cuff body that are spaced from one another in the width direction and are located between the first and second relatively wide electrically conductive contacts. A plurality of electrical conductors may be electrically connected to the electrically conductive contacts and extend through the lead body to the proximal end of the lead body. The present inventions also include systems with an implantable pulse generator or other implantable stimulation device in combination with such an electrode lead.
A method in accordance with at least one of the present inventions includes the steps of placing a helical nerve cuff of an electrode lead on the hypoglossal nerve (HGN) that is configured for placement on either one of the HGN trunk and the branch of the HGN that is responsible for protruding the tongue (HGN GM branch), applying stimulation energy to the HGN trunk with the helical nerve cuff in instances where the nerve cuff is on the HGN trunk, and applying stimulation energy to the HGN GM branch with the helical nerve cuff in instances where the nerve cuff is on the HGN GM branch.
Detailed descriptions of exemplary embodiments will be made with reference to the accompanying drawings.
The following is a detailed description of the best presently known modes of carrying out the inventions. This description is not to be taken in a limiting sense, but is made merely for the purpose of illustrating the general principles of the inventions.
Referring to
Turning to
The exemplary nerve cuff 102 is shown in various furled states in
Referring first to
The contacts 112-1 to 112-5 may be of any suitable construction. In the illustrated implementation, the cuff body 110 includes a front layer 114 that will face the HGN trunk or branch and a rear layer 116 that will face away from the HGN trunk or branch. Five conductive members 118-1 to 118-5 are located between the front layer 114 and rear layer 116. The conductive members 118-1 to 118-5 are exposed by way of openings 120-1 to 120-5 in the cuff body front layer 114. The openings 120-1 to 120-5 extend from the outer surface of the front layer 114 to the associated conductive members 118-1 to 118-5, and the exposed portions of the conductive members 118-1 to 118-5 define the contacts 112-1 to 114-5.
The contacts 112-1 to 112-5 in the illustrated embodiment may be electrically connected to the plurality of contacts 108 on the lead connector 106 (
The exemplary cuff body 110 may be formed from any suitable material. Such materials may be biologically compatible, electrically insulative, elastic and capable of functioning in the manner described herein. By way of example, but not limitation, suitable cuff body materials include silicone, polyurethane and liquid crystal polymers that are pliable enough to allow a clinician to unfurl the cuff body 110 (and nerve cuff 102) and place the nerve cuff around the HGN trunk (or HGN GM branch). The exemplary materials should also be resilient enough to cause the nerve cuff return to the pre-shaped furled state illustrated in
It should be noted here that in the state illustrated in
The dimensions of the present nerve cuffs, including the various elements thereof, may by any dimensions that result in the nerve cuffs functioning as intended. With respect to the dimensions of the cuff body 110 of the exemplary nerve cuff 102, and referring to
Turning to
The sensing circuitry 210 in the illustrated embodiment may be connected to one or more sensors (not shown) that are contained within the outer case 204. Alternatively, or in addition, the sensors may be affixed to the exterior of the outer case 204 or positioned at a remote site within the body and coupled to the IPG 200 with a connecting lead. The sensing circuitry 210 can detect physiological artifacts that are caused by respiration (e.g., motion or ribcage movement), which are proxies for respiratory phases, such as inspiration and expiration or, if no movement occurs, to indicate when breathing stops. Suitable sensors include, but are not limited to, inertial sensors, bioimpedance sensors, pressure sensors, gyroscopes, ECG electrodes, temperature sensors, GPS sensors, and combinations thereof. The memory 212 stores data gathered by the sensing circuitry 210, programming instructions and stimulation parameters. The control circuitry 208 analyzes the sensed data to determine when stimulation should be delivered. The communication circuitry 214 is configured to wirelessly communicates with the clinician's programming unit 300 and patient remote 400 using radio frequency signals.
The control circuitry 208 may apply stimulation energy to either the HGN trunk or an HGN branch (e.g. the HGN GM branch) in various stimulation methodologies by way of the cuff 102 when the patient is in the inspiratory phase of respiration, and other conditions for stimulation are met, thereby causing anterior displacement of the tongue to keep the upper airway unobstructed. The control circuitry 208 causes the stimulation circuitry 206 to apply stimulation in the form of a train of stimulation pulses during these inspiratory phases of the respiratory cycle (or slightly before the inspiration and ending at the end of inspiration) and not the remainder of the respiration cycle. The train of stimulus pulses may be set to a constant time duration or may change dynamically based on a predictive algorithm that determines the duration of the inspiratory phase of the respiratory cycle.
Any combination of contacts and stimulation mode may be employed so long as the desired therapeutic result is achieved. One exemplary stimulation methodology is illustrated in
Another exemplary stimulation methodology is illustrated in
In the exemplary stimulation methodology is illustrated in
Another exemplary nerve cuff is generally represented by reference numeral 102a in
Like the contacts 112-1 to 112-5, the contacts 113-1 and 113-2 may be of any suitable construction. In the illustrated implementation, and referring more specifically to
The exemplary nerve cuff 102a is shown in its pre-shaped furled state in
One exemplary stimulation methodology is illustrated in
Another exemplary stimulation methodology is illustrated in
Although the inventions disclosed herein have been described in terms of the preferred embodiments above, numerous modifications and/or additions to the above-described preferred embodiments would be readily apparent to one skilled in the art. By way of example, but not limitation, the present inventions are applicable to other portions of the peripheral nervous system, such as the glossopharyngeal, vagus, and optic nerves, as well as other nerves, and present inventions include stimulating these nerves with the nerve cuffs disclosed herein. It is intended that the scope of the present inventions extend to all such modifications and/or additions. The inventions include any and all combinations of the elements from the various embodiments disclosed in the specification. The scope of the present inventions is limited solely by the claims set forth below.
This application claims the benefit of U.S. Provisional Application No. 63/220,007, filed Jul. 9, 2021, and entitled “Parallel Electrode Helical Cuff Configurations,” which is incorporated herein by reference.
Number | Name | Date | Kind |
---|---|---|---|
4573481 | Bullara | Mar 1986 | A |
4602624 | Naples et al. | Jul 1986 | A |
4940065 | Tanagho et al. | Jul 1990 | A |
5251634 | Weinberg | Oct 1993 | A |
5400784 | Durand et al. | Mar 1995 | A |
5439485 | Mar et al. | Aug 1995 | A |
5487756 | Kallesoe et al. | Jan 1996 | A |
5634462 | Tyler et al. | Jun 1997 | A |
5919220 | Stieglitz et al. | Jul 1999 | A |
6066165 | Racz | May 2000 | A |
6210339 | Kiepen et al. | Apr 2001 | B1 |
6292703 | Meier et al. | Sep 2001 | B1 |
7383090 | O'Brien et al. | Jun 2008 | B2 |
7794256 | Sochor | Sep 2010 | B1 |
7809442 | Bolea et al. | Oct 2010 | B2 |
8116882 | Kowalczewski | Feb 2012 | B2 |
8155757 | Neisz et al. | Apr 2012 | B1 |
8224449 | Carbunaru et al. | Jul 2012 | B2 |
8311645 | Bolea et al. | Nov 2012 | B2 |
8340785 | Bonde et al. | Dec 2012 | B2 |
8660665 | Walter et al. | Feb 2014 | B2 |
8792973 | Moran et al. | Jul 2014 | B2 |
8934992 | Johnson et al. | Jan 2015 | B2 |
9186511 | Bolea | Nov 2015 | B2 |
9227053 | Bonde et al. | Jan 2016 | B2 |
9549708 | Mercanzini et al. | Jan 2017 | B2 |
9603538 | Fisher et al. | Mar 2017 | B2 |
9849288 | Meadows et al. | Dec 2017 | B2 |
9889304 | Mercanzini | Feb 2018 | B2 |
9931045 | Brunnett et al. | Apr 2018 | B2 |
10758723 | Fang et al. | Sep 2020 | B2 |
20020198582 | Edell et al. | Dec 2002 | A1 |
20050070982 | Heruth et al. | Mar 2005 | A1 |
20050186829 | Balsells | Aug 2005 | A1 |
20060030919 | Mrva et al. | Feb 2006 | A1 |
20070123765 | Hetke et al. | May 2007 | A1 |
20080082137 | Kieval et al. | Apr 2008 | A1 |
20080092246 | Shintani | Apr 2008 | A1 |
20090045772 | Cook et al. | Feb 2009 | A1 |
20090132042 | Hetke et al. | May 2009 | A1 |
20090210042 | Kowalczewski | Aug 2009 | A1 |
20100305674 | Zarembo et al. | Dec 2010 | A1 |
20100331933 | Carbunaru et al. | Dec 2010 | A1 |
20110066196 | Alexander et al. | Mar 2011 | A1 |
20110130815 | Gibson et al. | Jun 2011 | A1 |
20110154655 | Hetke et al. | Jun 2011 | A1 |
20110251473 | Moran et al. | Oct 2011 | A1 |
20110301665 | Mercanzini et al. | Dec 2011 | A1 |
20120150255 | Lindenthaler et al. | Jun 2012 | A1 |
20120154256 | Grover et al. | Jun 2012 | A1 |
20120316417 | Vetter | Dec 2012 | A1 |
20130030352 | Seymour et al. | Jan 2013 | A1 |
20130085361 | Mercanzini et al. | Apr 2013 | A1 |
20130090711 | Ramachandran et al. | Apr 2013 | A1 |
20130150938 | Carbunaru et al. | Jun 2013 | A1 |
20130304174 | Langhals et al. | Nov 2013 | A1 |
20140005763 | Cederna et al. | Jan 2014 | A1 |
20140058482 | Gupta et al. | Feb 2014 | A1 |
20140163659 | Boling | Jun 2014 | A1 |
20140188202 | Zarembo et al. | Jul 2014 | A1 |
20140228905 | Bolea | Aug 2014 | A1 |
20140303703 | Mercanzini et al. | Oct 2014 | A1 |
20150119673 | Pellinen et al. | Apr 2015 | A1 |
20150128413 | Vetter et al. | May 2015 | A1 |
20150157854 | Hetke et al. | Jun 2015 | A1 |
20150174396 | Fisher et al. | Jun 2015 | A1 |
20150224307 | Bolea | Aug 2015 | A1 |
20150374975 | Callegari et al. | Dec 2015 | A1 |
20160184581 | Bonde et al. | Jun 2016 | A1 |
20160199637 | Xu et al. | Jul 2016 | A1 |
20160287863 | Mercanzini et al. | Oct 2016 | A1 |
20160331326 | Xiang et al. | Nov 2016 | A1 |
20160331994 | Smith et al. | Nov 2016 | A1 |
20170266436 | Suwito et al. | Sep 2017 | A1 |
20180117313 | Schmidt et al. | May 2018 | A1 |
20180221660 | Suri et al. | Aug 2018 | A1 |
20180318577 | Ng et al. | Nov 2018 | A1 |
20180318578 | Ng et al. | Nov 2018 | A1 |
20190060646 | Ng et al. | Feb 2019 | A1 |
20190282805 | Schmidt et al. | Sep 2019 | A1 |
20200069935 | Johnson et al. | Mar 2020 | A1 |
20200083922 | Hong et al. | Mar 2020 | A1 |
20200146583 | Hestad et al. | May 2020 | A1 |
20200230412 | Rondoni et al. | Jul 2020 | A1 |
20200306526 | Doguet et al. | Oct 2020 | A1 |
20210205662 | Lu et al. | Jul 2021 | A1 |
20220062629 | Dearden | Mar 2022 | A1 |
20220088374 | Ackermann et al. | Mar 2022 | A1 |
20220313987 | Jenny et al. | Oct 2022 | A1 |
Number | Date | Country |
---|---|---|
WO 2008092246 | Aug 2008 | WO |
WO 2009045772 | Apr 2009 | WO |
WO 2012154256 | Nov 2012 | WO |
WO 2013188871 | Dec 2013 | WO |
WO 2016039768 | Mar 2016 | WO |
WO 2020182293 | Sep 2020 | WO |
Entry |
---|
U.S. Appl. No. 17/463,630, filed Sep. 1, 2021. |
U.S. Appl. No. 17/683,598, filed Mar. 1, 2022. |
PCT International Search and Written Opinion dated Mar. 28, 2022 for PCT App. Ser. No. PCT/US2021/048585. |
U.S. Appl. No. 17/463,611, filed Sep. 1, 2021, 20220062629 A1. |
U.S. Appl. No. 17/463,630, filed Sep. 1, 2021, 20230010510 A1. |
U.S. Appl. No. 17/683,598, filed Mar. 1, 2022, 20220313987 A1. |
U.S. Appl. No. 17/710,570, filed Mar. 31, 2022. |
U.S. Appl. No. 18/186,927, filed Mar. 20, 2023. |
Number | Date | Country | |
---|---|---|---|
20230010510 A1 | Jan 2023 | US |
Number | Date | Country | |
---|---|---|---|
63220007 | Jul 2021 | US |